Stocks and Investing
Stocks and Investing
Mon, December 11, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sun, December 10, 2023
[ 12:00 AM ] - WOPRAI
Fri, December 8, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matt Hewitt Maintained (CDMO) at Strong Buy with Decreased Target to $16 on, Dec 8th, 2023
Matt Hewitt of Craig-Hallum, Maintained "Avid Bioservices, Inc." (CDMO) at Strong Buy with Decreased Target from $22 to $16 on, Dec 8th, 2023.
Matt has made no other calls on CDMO in the last 4 months.
There is 1 other peer that has a rating on CDMO. Out of the 1 peers that are also analyzing CDMO, all agrees with Matt's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Max Smock of "William Blair" Initiated at Hold on, Thursday, September 28th, 2023
Contributing Sources